Oragenics receives US patent for ProBiora3.

Florida-based biopharmaceutical company Oragenics Inc announced the issuance of patent number 7931892 from the US Patent and Trademark office for ProBiora3, a proprietary blend of naturally occurring oral bacteria shown to produce a wide range of oral care benefits. ProBiora3 contains three strains of beneficial oral bacteria that help maintain a healthy microbial balance in the mouth. It is 100% natural and is made in the USA in an FDA-registered and GMP-certified facility. Issuance of the patent enables Oragenics to immediately pursue global private label and licensing opportunities in major product categories such as food and beverage, health and wellness, pet care and nutrition. The …